董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| A. Gregory Sorensen | 男 | Executive Vice President, Chief Science Officer, Director | 63 | 256.32万美元 | 120.19 | 2026-01-07 |
| Laura P. Jacobs | 女 | Director | 68 | 26.85万美元 | 2.70 | 2026-01-07 |
| Howard G. Berger | 男 | President, Chief Executive Officer and Chairman of the Board | 80 | 1208.79万美元 | 51.84 | 2026-01-07 |
| Lawrence L. Levitt | 男 | Director | 83 | 27.35万美元 | 16.50 | 2026-01-07 |
| David L. Swartz | 男 | Director | 82 | 30.85万美元 | 21.38 | 2026-01-07 |
| Gregory E. Spurlock | 男 | Director | 64 | 25.10万美元 | 0.53 | 2026-01-07 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Mital Patel | 男 | Executive Vice President and Chief Operating Officer | 40 | 305.56万美元 | 32.07 | 2026-01-07 |
| Cornelis Wesdorp | 男 | President and Chief Executive Officer- Digital Health | 48 | 432.74万美元 | 未持股 | 2026-01-07 |
| David J. Katz | 男 | Executive Vice President, Chief Legal Officer and Corporate Secretary | 61 | 未披露 | 未持股 | 2026-01-07 |
| Ranjan Jayanathan | 男 | Executive Vice President, Chief Information Officer | 69 | 未披露 | 未持股 | 2026-01-07 |
| A. Gregory Sorensen | 男 | Executive Vice President, Chief Science Officer, Director | 63 | 256.32万美元 | 120.19 | 2026-01-07 |
| Howard G. Berger | 男 | President, Chief Executive Officer and Chairman of the Board | 80 | 1208.79万美元 | 51.84 | 2026-01-07 |
| Norman R. Hames | 男 | President and Chief Executive Officer, Western Operations | 70 | 323.81万美元 | 43.04 | 2026-01-07 |
| Stephen M. Forthuber | 男 | President and Chief Executive Officer, Eastern Operations | 65 | 325.44万美元 | 76.26 | 2026-01-07 |
| Mark D. Stolper | 男 | Executive Vice President and Chief Financial Officer | 54 | 283.35万美元 | 23.98 | 2026-01-07 |
| Michael N. Murdock | 男 | Executive Vice President, Mergers and Acquisitions | 71 | 75.65万美元 | 未持股 | 2026-01-07 |
董事简历
中英对照 | 中文 | 英文- A. Gregory Sorensen
-
A. Gregory Sorensen，于2023年8月被任命为首席科学官和董事。Sorensen博士曾担任该公司旗下专注于Radnet，Inc. ing人工智能和深度学习方法的DeepHealth，Inc.（“DeepHealth”）子公司的首席执行官，该公司以乳腺癌成像为重点推进医疗保健。公司于2020年6月收购DeepHealth。Sorensen博士曾于2011年至2015年担任Siemens Healthcare North America总裁兼首席执行官。在此之前，他曾在哈佛医学院担任教授，并在麻省总医院担任神经放射科医生，他曾于1990年至2011年在该医院工作。Sorensen博士目前担任：IMRIS Deerfield Imaging，Inc.的董事会执行主席，该公司专注于整合神经外科环境中的成像技术；RealMIDX，Inc.的董事会成员，这是一家由KonicaMinolta全资拥有的综合诊断公司；以及费森尤斯医疗 AG & Co KGaA的监事会成员，该公司是一家为慢性肾衰竭患者提供产品和服务的供应商。Sorensen博士曾于2018年至2023年在Siemens Healthineers担任监事会成员。Sorensen博士拥有加州理工学院生物学学士学位、杨百翰大学计算机科学硕士学位和哈佛医学院医学博士学位。
A. Gregory Sorensen,was appointed as Chief Science Officer and as a director in August 2023. Dr. Sorensen has served as the Chief Executive Officer of Radnet, Inc. DeepHealth, Inc. ("DeepHealth") subsidiary of the Company that is focused on Radnet, Inc. ing artificial intelligence and deep learning methods to advance medical care with a special emphasis on breast cancer imaging. The Company acquired DeepHealth in June 2020. Dr. Sorensen served as the President and Chief Executive Officer of Siemens Healthcare North America from 2011 to 2015. Prior to that, he served as a Professor at Harvard Medical School and as a neuroradiologist at Massachusetts General Hospital, where he worked from 1990 to 2011. Dr. Sorensen currently serves as: the Executive Chairman of the board of directors of IMRIS, Deerfield Imaging, Inc., which is focused on the integration of imaging technologies in a neurosurgical setting; a member of the board of directors for RealmIDX, Inc., an integrated diagnostics company wholly owned by KonicaMinolta; and a member of the Supervisory Board for Fresenius Medical Care AG & Co KGaA, a provider of products and services for people with chronic kidney failure. Dr. Sorensen served as a Supervisory Board Member at Siemens Healthineers from 2018 to 2023. Dr. Sorensen holds a B.S. in biology from the California Institute of Technology, an M.S. in computer science from Brigham Young University, and an M.D. degree from Harvard Medical School. - A. Gregory Sorensen，于2023年8月被任命为首席科学官和董事。Sorensen博士曾担任该公司旗下专注于Radnet，Inc. ing人工智能和深度学习方法的DeepHealth，Inc.（“DeepHealth”）子公司的首席执行官，该公司以乳腺癌成像为重点推进医疗保健。公司于2020年6月收购DeepHealth。Sorensen博士曾于2011年至2015年担任Siemens Healthcare North America总裁兼首席执行官。在此之前，他曾在哈佛医学院担任教授，并在麻省总医院担任神经放射科医生，他曾于1990年至2011年在该医院工作。Sorensen博士目前担任：IMRIS Deerfield Imaging，Inc.的董事会执行主席，该公司专注于整合神经外科环境中的成像技术；RealMIDX，Inc.的董事会成员，这是一家由KonicaMinolta全资拥有的综合诊断公司；以及费森尤斯医疗 AG & Co KGaA的监事会成员，该公司是一家为慢性肾衰竭患者提供产品和服务的供应商。Sorensen博士曾于2018年至2023年在Siemens Healthineers担任监事会成员。Sorensen博士拥有加州理工学院生物学学士学位、杨百翰大学计算机科学硕士学位和哈佛医学院医学博士学位。
- A. Gregory Sorensen,was appointed as Chief Science Officer and as a director in August 2023. Dr. Sorensen has served as the Chief Executive Officer of Radnet, Inc. DeepHealth, Inc. ("DeepHealth") subsidiary of the Company that is focused on Radnet, Inc. ing artificial intelligence and deep learning methods to advance medical care with a special emphasis on breast cancer imaging. The Company acquired DeepHealth in June 2020. Dr. Sorensen served as the President and Chief Executive Officer of Siemens Healthcare North America from 2011 to 2015. Prior to that, he served as a Professor at Harvard Medical School and as a neuroradiologist at Massachusetts General Hospital, where he worked from 1990 to 2011. Dr. Sorensen currently serves as: the Executive Chairman of the board of directors of IMRIS, Deerfield Imaging, Inc., which is focused on the integration of imaging technologies in a neurosurgical setting; a member of the board of directors for RealmIDX, Inc., an integrated diagnostics company wholly owned by KonicaMinolta; and a member of the Supervisory Board for Fresenius Medical Care AG & Co KGaA, a provider of products and services for people with chronic kidney failure. Dr. Sorensen served as a Supervisory Board Member at Siemens Healthineers from 2018 to 2023. Dr. Sorensen holds a B.S. in biology from the California Institute of Technology, an M.S. in computer science from Brigham Young University, and an M.D. degree from Harvard Medical School.
- Laura P. Jacobs
-
Laura P. Jacobs，自2020年起担任审计委员会、RadNet, Inc.提名和治理委员会以及薪酬委员会成员。雅各布斯女士于2020年从GE Healthcare Partners管理负责人的职位上退休，她自1990年以来一直在该公司工作。Jacobs女士于2015年至2019年领导公司的美国医疗保健管理咨询业务，是其前身咨询公司卡姆登集团的创始负责人和执行领导。她目前是Vizient咨询部门Kaufman Hall的兼职高级顾问。她是医疗保健趋势及其对供应商影响方面的全国性专家，在过去40年中一直参与医疗保健管理，包括在GE Healthcare Partners/The Camden Group工作的30年，就战略、运营和财务业绩改善计划为医疗保健供应商提供建议。Jacobs女士曾就增长战略、技术采用和财务业绩改善向医师组织、复杂的卫生健康系统和其他医疗保健实体提供建议。Jacobs女士领导了卫生系统的战略、财务和运营重新设计，包括改变决策和提供护理的框架。Jacobs女士领导了供应商组织的组织和薪酬重新设计，以实现更大的整合和一致的激励。
Laura P. Jacobs,has been a member of Audit Committee, Radnet, Inc. Nominating and Governance Committee and Compensation Committee since 2020. Ms. Jacobs retired from her position as managing principal of GE Healthcare Partners in 2020, where she worked since 1990. Ms. Jacobs led the firm's US healthcare management consulting business from 2015 to 2019 and was a founding principal and executive leader of its predecessor consulting firm, The Camden Group. She is currently a part-time Senior Advisor for Kaufman Hall, a consulting division of Vizient. She is a national expert on healthcare trends and their impact on providers and has been involved in healthcare management for the past 40 years, including the 30 years with GE Healthcare Partners/The Camden Group, advising healthcare providers regarding strategies, operations and financial performance improvement initiatives. Ms. Jacobs has advised physician organizations, complex health systems and other healthcare entities on strategies for growth, technology adoption and financial performance improvement. Ms. Jacobs has led strategic, financial and operational redesign of health systems, including transforming the framework for decision-making and care delivery. Ms. Jacobs has led the organizational and compensation redesign for provider organizations to achieve greater integration and aligned incentives. - Laura P. Jacobs，自2020年起担任审计委员会、RadNet, Inc.提名和治理委员会以及薪酬委员会成员。雅各布斯女士于2020年从GE Healthcare Partners管理负责人的职位上退休，她自1990年以来一直在该公司工作。Jacobs女士于2015年至2019年领导公司的美国医疗保健管理咨询业务，是其前身咨询公司卡姆登集团的创始负责人和执行领导。她目前是Vizient咨询部门Kaufman Hall的兼职高级顾问。她是医疗保健趋势及其对供应商影响方面的全国性专家，在过去40年中一直参与医疗保健管理，包括在GE Healthcare Partners/The Camden Group工作的30年，就战略、运营和财务业绩改善计划为医疗保健供应商提供建议。Jacobs女士曾就增长战略、技术采用和财务业绩改善向医师组织、复杂的卫生健康系统和其他医疗保健实体提供建议。Jacobs女士领导了卫生系统的战略、财务和运营重新设计，包括改变决策和提供护理的框架。Jacobs女士领导了供应商组织的组织和薪酬重新设计，以实现更大的整合和一致的激励。
- Laura P. Jacobs,has been a member of Audit Committee, Radnet, Inc. Nominating and Governance Committee and Compensation Committee since 2020. Ms. Jacobs retired from her position as managing principal of GE Healthcare Partners in 2020, where she worked since 1990. Ms. Jacobs led the firm's US healthcare management consulting business from 2015 to 2019 and was a founding principal and executive leader of its predecessor consulting firm, The Camden Group. She is currently a part-time Senior Advisor for Kaufman Hall, a consulting division of Vizient. She is a national expert on healthcare trends and their impact on providers and has been involved in healthcare management for the past 40 years, including the 30 years with GE Healthcare Partners/The Camden Group, advising healthcare providers regarding strategies, operations and financial performance improvement initiatives. Ms. Jacobs has advised physician organizations, complex health systems and other healthcare entities on strategies for growth, technology adoption and financial performance improvement. Ms. Jacobs has led strategic, financial and operational redesign of health systems, including transforming the framework for decision-making and care delivery. Ms. Jacobs has led the organizational and compensation redesign for provider organizations to achieve greater integration and aligned incentives.
- Howard G. Berger
-
Howard G. Berger，自1987年起担任RadNet及其前身实体的总裁兼首席执行官。Berger博士在Illinois大学医学院获得医学博士学位，获得核医学委员会认证并接受过内科住院医师培训，还在加州大学系统的医学物理硕士课程中接受过培训。Berger博士还是拥有Beverly Radiology Medical Group III（“BRMG”）的实体的总裁或联合总裁。
Howard G. Berger,has served as President and Chief Executive Officer of RadNet and its predecessor entities since 1987. Dr. Berger received his M.D. at the University of Illinois Medical School, is Board Certified in Nuclear Medicine and trained in an Internal Medicine residency, as well as in a master's program in medical physics in the University of California system. Dr. Berger is also the president or co-president of the entities that own Beverly Radiology Medical Group III ("BRMG"). - Howard G. Berger，自1987年起担任RadNet及其前身实体的总裁兼首席执行官。Berger博士在Illinois大学医学院获得医学博士学位，获得核医学委员会认证并接受过内科住院医师培训，还在加州大学系统的医学物理硕士课程中接受过培训。Berger博士还是拥有Beverly Radiology Medical Group III（“BRMG”）的实体的总裁或联合总裁。
- Howard G. Berger,has served as President and Chief Executive Officer of RadNet and its predecessor entities since 1987. Dr. Berger received his M.D. at the University of Illinois Medical School, is Board Certified in Nuclear Medicine and trained in an Internal Medicine residency, as well as in a master's program in medical physics in the University of California system. Dr. Berger is also the president or co-president of the entities that own Beverly Radiology Medical Group III ("BRMG").
- Lawrence L. Levitt
-
Lawrence L. Levitt，他是注册会计师，在加利福尼亚大学洛杉矶分校（University of California Los Angeles）获得会计学工商管理学硕士学位。1987年起，他担任管理私人投资基金的Canyon Management Company的总裁和首席财务官。
Lawrence L. Levitt,has been a member of Audit Committee since March 2005 and a member of Nominating and Governance Committee since 2011. Mr. Levitt has served as Chair of Compensation Committee since 2007. Mr. Levitt is a certified public accountant and received his MBA in Accounting from the University of California Los Angeles. Since 1987, Mr. Levitt has been the President, Chief Financial Officer of Canyon Management Company, a company which manages a privately held investment fund. - Lawrence L. Levitt，他是注册会计师，在加利福尼亚大学洛杉矶分校（University of California Los Angeles）获得会计学工商管理学硕士学位。1987年起，他担任管理私人投资基金的Canyon Management Company的总裁和首席财务官。
- Lawrence L. Levitt,has been a member of Audit Committee since March 2005 and a member of Nominating and Governance Committee since 2011. Mr. Levitt has served as Chair of Compensation Committee since 2007. Mr. Levitt is a certified public accountant and received his MBA in Accounting from the University of California Los Angeles. Since 1987, Mr. Levitt has been the President, Chief Financial Officer of Canyon Management Company, a company which manages a privately held investment fund.
- David L. Swartz
-
David L. Swartz，他是注册会计师，为客户提供会计与咨询服务 。2012年11月起，他担任加州州会计委员会（California State Board of Accountancy）董事会成员，并曾担任总裁。1993年前，他担任的主理合伙人和国际会计师事务所全国董事会成员。1993至2008年，他担任Good, Swartz, Brown & Berns LLP的主理合伙人，2008年该公司被J.H. Cohn LLP收购。2008至2010年，他担任J.H. Cohn LLP的合伙人；2010年起，拥有并继续运营自己的咨询服务公司。他还曾是上市购物中心与发展公司的首席财务官。
David L. Swartz,has been Chair of Audit Committee since 2004, has been a member of Nominating and Governance Committee since 2007, a member of Compensation Committee since 2007 and was appointed as Lead Independent Director in 2011. Mr. Swartz is a certified public accountant (retired) with experience providing accounting and advisory services to clients. Since 2010, Mr. Swartz has owned and continues to operate his own consulting services firm. Mr. Swartz served as a member of the Board of Directors of the California State Board of Accountancy until November 2012 and previously served as its president. From 2008 to 2010, Mr. Swartz served as a partner at J.H. Cohn LLP. Between 1990 and 2008, Mr. Swartz served as the managing partner of Good, Swartz, Brown & Berns LLP which was acquired by J.H. Cohn LLP in 2008. Prior to 1988, Mr. Swartz served as managing partner and was on the national Board of Directors of a 50 office international accounting firm. - David L. Swartz，他是注册会计师，为客户提供会计与咨询服务 。2012年11月起，他担任加州州会计委员会（California State Board of Accountancy）董事会成员，并曾担任总裁。1993年前，他担任的主理合伙人和国际会计师事务所全国董事会成员。1993至2008年，他担任Good, Swartz, Brown & Berns LLP的主理合伙人，2008年该公司被J.H. Cohn LLP收购。2008至2010年，他担任J.H. Cohn LLP的合伙人；2010年起，拥有并继续运营自己的咨询服务公司。他还曾是上市购物中心与发展公司的首席财务官。
- David L. Swartz,has been Chair of Audit Committee since 2004, has been a member of Nominating and Governance Committee since 2007, a member of Compensation Committee since 2007 and was appointed as Lead Independent Director in 2011. Mr. Swartz is a certified public accountant (retired) with experience providing accounting and advisory services to clients. Since 2010, Mr. Swartz has owned and continues to operate his own consulting services firm. Mr. Swartz served as a member of the Board of Directors of the California State Board of Accountancy until November 2012 and previously served as its president. From 2008 to 2010, Mr. Swartz served as a partner at J.H. Cohn LLP. Between 1990 and 2008, Mr. Swartz served as the managing partner of Good, Swartz, Brown & Berns LLP which was acquired by J.H. Cohn LLP in 2008. Prior to 1988, Mr. Swartz served as managing partner and was on the national Board of Directors of a 50 office international accounting firm.
- Gregory E. Spurlock
-
Gregory E. Spurlock在2013年4月被任命为肿瘤联盟公司总裁。他最初在2011年4月加入肿瘤联盟（公司收购US Radiosurgery的一部分）并担任首席管理官，随后在2012年6月担任业务发展和合同运营部高级副总裁。现在，Spurlock先生负责监管肿瘤联盟所有的SRS设备和放射治疗中心。Spurlock先生关注于ancillary服务、医师关系和设备发展。Spurlock于2004年加入US Radiosurgery，从2004年到2011年被联盟收购在公司及其子公司担任各种行政领导职务，包括US Radiosurgery的首席运营官、NeoSpine的执行副董事以及Imaging One公司的首席执行官。在2004年前Spurlock先生还在Tennessee Orthopaedic Alliance以及位于洛杉矶的Kerlan-Jobe Orthopaedic Clinic担任执行董事。
Gregory E. Spurlock,has been a member of Compensation Committee and Nominating and Governance Committee since 2021. Mr. Spurlock is currently a Senior Advisor to Global Medical Response, a KKR company with over 38,000 employees that provides emergency response to the ill and injured. From to August 2019 to August 2024, Mr. Spurlock served as a Senior Advisor to LLR Partners, a Philadelphia-based private equity fund with a focus on health care. He retired in 2019 as President of Alliance Healthcare Services, where he directed operations for their professional, technical, and global hospital-based services, encompassing 40 centers across 19 states. Mr. Spurlock helped lead U.S. Radiosurgery, LLC, through its acquisition by Alliance HealthCare Services in 2011. As a member of the senior executive team, he led Alliance Healthcare's transition from publicly traded to international privately-owned in 2017. Previous leadership includes work as the Director of the Tennessee Orthopaedic Alliance in Nashville and Executive Director of the Kerlan-Jobe Orthopedic Clinic in Los Angeles. Mr. Spurlock has served on a number of boards, including the CyberKnife Coalition, the Corporate Advisory Council of the American Society for Radiation Oncology, and the Board of Directors of the American Association of Orthopaedic Executives. He holds a Bachelor of Science degree from Virginia Tech. - Gregory E. Spurlock在2013年4月被任命为肿瘤联盟公司总裁。他最初在2011年4月加入肿瘤联盟（公司收购US Radiosurgery的一部分）并担任首席管理官，随后在2012年6月担任业务发展和合同运营部高级副总裁。现在，Spurlock先生负责监管肿瘤联盟所有的SRS设备和放射治疗中心。Spurlock先生关注于ancillary服务、医师关系和设备发展。Spurlock于2004年加入US Radiosurgery，从2004年到2011年被联盟收购在公司及其子公司担任各种行政领导职务，包括US Radiosurgery的首席运营官、NeoSpine的执行副董事以及Imaging One公司的首席执行官。在2004年前Spurlock先生还在Tennessee Orthopaedic Alliance以及位于洛杉矶的Kerlan-Jobe Orthopaedic Clinic担任执行董事。
- Gregory E. Spurlock,has been a member of Compensation Committee and Nominating and Governance Committee since 2021. Mr. Spurlock is currently a Senior Advisor to Global Medical Response, a KKR company with over 38,000 employees that provides emergency response to the ill and injured. From to August 2019 to August 2024, Mr. Spurlock served as a Senior Advisor to LLR Partners, a Philadelphia-based private equity fund with a focus on health care. He retired in 2019 as President of Alliance Healthcare Services, where he directed operations for their professional, technical, and global hospital-based services, encompassing 40 centers across 19 states. Mr. Spurlock helped lead U.S. Radiosurgery, LLC, through its acquisition by Alliance HealthCare Services in 2011. As a member of the senior executive team, he led Alliance Healthcare's transition from publicly traded to international privately-owned in 2017. Previous leadership includes work as the Director of the Tennessee Orthopaedic Alliance in Nashville and Executive Director of the Kerlan-Jobe Orthopedic Clinic in Los Angeles. Mr. Spurlock has served on a number of boards, including the CyberKnife Coalition, the Corporate Advisory Council of the American Society for Radiation Oncology, and the Board of Directors of the American Association of Orthopaedic Executives. He holds a Bachelor of Science degree from Virginia Tech.
高管简历
中英对照 | 中文 | 英文- Mital Patel
Mital Patel自2016年以来一直担任我们的财务计划和分析执行Vice President。Patel先生也一直在社区非常活跃，曾在几个非营利组织担任董事会席位。Patel先生于2010年在贝克斯菲尔德的加利福尼亚州立大学（California State University）获得工商管理学士学位后在我们开始了他的职业生涯。
Mital Patel,has served as Radnet, Inc. Executive Vice President of Financial Planning and Analysis since 2016 and Chief Administrative Officer since 2021. Mr. Patel directs national budgets and finance, provides counsel regarding corporate acquisitions, and identifies opportunities for the company to deliver cost-effective medical services. His background, experience and insight provide a critical and effective connection between Radnet, Inc. business units and management team. Mr. Patel began his career at RadNet in 2010. Prior to that time, Mr. Patel served as part of the management team at Truxtun Radiology before its acquisition by RadNet. Mr. Patel earned a B.A. degree in Business Administration, with a concentration Management and Marketing, from California State University in Bakersfield.- Mital Patel自2016年以来一直担任我们的财务计划和分析执行Vice President。Patel先生也一直在社区非常活跃，曾在几个非营利组织担任董事会席位。Patel先生于2010年在贝克斯菲尔德的加利福尼亚州立大学（California State University）获得工商管理学士学位后在我们开始了他的职业生涯。
- Mital Patel,has served as Radnet, Inc. Executive Vice President of Financial Planning and Analysis since 2016 and Chief Administrative Officer since 2021. Mr. Patel directs national budgets and finance, provides counsel regarding corporate acquisitions, and identifies opportunities for the company to deliver cost-effective medical services. His background, experience and insight provide a critical and effective connection between Radnet, Inc. business units and management team. Mr. Patel began his career at RadNet in 2010. Prior to that time, Mr. Patel served as part of the management team at Truxtun Radiology before its acquisition by RadNet. Mr. Patel earned a B.A. degree in Business Administration, with a concentration Management and Marketing, from California State University in Bakersfield.
- Cornelis Wesdorp
Cornelis Wesdorp，自2024年起担任雷网执行官，目前担任RadNet, Inc.总裁兼首席运营官-数字健康。在加入雷网之前，Wesdorp先生曾担任伦敦私募股权公司Hellman & Friedman的董事总经理，自2023年2月起共同领导欧盟运营团队。从2017年到2022年，Wesdorp先生在阿姆斯特丹的菲利普斯集团担任高管，最初担任执行副总裁，负责监督诊断成像业务，之后于2020年晋升为辉立的执行委员会，负责监督价值数十亿欧元的精准诊断部门，专注于为包括成像系统、信息学和人工智能在内的健康系统提供诊断成像解决方案。2011年至2016年，Wesdorp先生担任伦敦私募股权公司贝恩资本的执行副总裁，担任投资组合公司的各种运营合伙人角色。2006年至2011年，他在位于荷兰埃因霍温的半导体制造和设计公司恩智浦半导体担任多个管理职务。韦斯多普先生的职业生涯始于阿姆斯特丹的麦肯锡公司。Wesdorp先生获得了阿姆斯特丹大学的物理学硕士学位和阿姆斯特丹自由大学的实验原子物理学博士学位。
Cornelis Wesdorp,has served as an executive officer of RadNet since 2024 and currently serves as Radnet, Inc. President and Chief Operating Officer-Digital Health. Prior to joining RadNet, Mr. Wesdorp served as a Managing Director of the private equity firm Hellman & Friedman in London, where he co-led the EU Operations group since February 2023. From 2017 to 2022 Mr. Wesdorp was an executive with Phillips Group in Amsterdam, starting as an executive vice president overseeing the Diagnostic Imaging businesses before being promoted in 2020 to Phillip's executive committee with responsibility for overseeing the multi-billion euro Precision Diagnosis Division, focused on diagnostic imaging solutions for health systems including imaging systems, informatics and artificial intelligence. From 2011 to 2016, Mr. Wesdorp was an executive vice president with the private equity firm Bain Capital in London, performing various operating partner roles for portfolio companies. From 2006 to 2011, he served in various management roles with NXP Semiconductor, a semiconductor manufacturing and design company based in Eindhoven, Netherlands. Mr. Wesdorp began his career at McKinsey & Company in Amsterdam. Mr. Wesdorp earned a Masters Degree in Physics from the University of Amsterdam and a PhD in Experimental Atomic Physics from Vrije University in Amsterdam.- Cornelis Wesdorp，自2024年起担任雷网执行官，目前担任RadNet, Inc.总裁兼首席运营官-数字健康。在加入雷网之前，Wesdorp先生曾担任伦敦私募股权公司Hellman & Friedman的董事总经理，自2023年2月起共同领导欧盟运营团队。从2017年到2022年，Wesdorp先生在阿姆斯特丹的菲利普斯集团担任高管，最初担任执行副总裁，负责监督诊断成像业务，之后于2020年晋升为辉立的执行委员会，负责监督价值数十亿欧元的精准诊断部门，专注于为包括成像系统、信息学和人工智能在内的健康系统提供诊断成像解决方案。2011年至2016年，Wesdorp先生担任伦敦私募股权公司贝恩资本的执行副总裁，担任投资组合公司的各种运营合伙人角色。2006年至2011年，他在位于荷兰埃因霍温的半导体制造和设计公司恩智浦半导体担任多个管理职务。韦斯多普先生的职业生涯始于阿姆斯特丹的麦肯锡公司。Wesdorp先生获得了阿姆斯特丹大学的物理学硕士学位和阿姆斯特丹自由大学的实验原子物理学博士学位。
- Cornelis Wesdorp,has served as an executive officer of RadNet since 2024 and currently serves as Radnet, Inc. President and Chief Operating Officer-Digital Health. Prior to joining RadNet, Mr. Wesdorp served as a Managing Director of the private equity firm Hellman & Friedman in London, where he co-led the EU Operations group since February 2023. From 2017 to 2022 Mr. Wesdorp was an executive with Phillips Group in Amsterdam, starting as an executive vice president overseeing the Diagnostic Imaging businesses before being promoted in 2020 to Phillip's executive committee with responsibility for overseeing the multi-billion euro Precision Diagnosis Division, focused on diagnostic imaging solutions for health systems including imaging systems, informatics and artificial intelligence. From 2011 to 2016, Mr. Wesdorp was an executive vice president with the private equity firm Bain Capital in London, performing various operating partner roles for portfolio companies. From 2006 to 2011, he served in various management roles with NXP Semiconductor, a semiconductor manufacturing and design company based in Eindhoven, Netherlands. Mr. Wesdorp began his career at McKinsey & Company in Amsterdam. Mr. Wesdorp earned a Masters Degree in Physics from the University of Amsterdam and a PhD in Experimental Atomic Physics from Vrije University in Amsterdam.
- David J. Katz
David J. Katz，自2020年3月起担任执行副总裁兼首席法务官。Katz先生自2021年4月起担任公司秘书。Katz先生从国际律师事务所Perkins Coie LLP加入雷网，在那里他担任了20年的合伙人。在加入雷网之前，Katz先生已经私人执业30年。Katz先生负责监督雷网的所有法律事务，包括但不限于合并、收购、证券和合资企业。卡茨先生自1990年以来还担任洛杉矶县警长预备役副手，曾两次获得洛杉矶县警长部门的英勇勋章。
David J. Katz,has served as Executive Vice President and Chief Legal Officer since March 2020. Mr. Katz has served as Corporate Secretary since April 2021. Mr. Katz joined RadNet from the international law firm Perkins Coie LLP, where he was a partner for 20 years. Mr. Katz was in private practice for 30 years before joining RadNet. Mr. Katz is responsible for overseeing all of RadNet's legal matters including, without limitation, mergers, acquisitions, securities and joint ventures. Mr. Katz has also served as a Los Angeles County Sheriff Reserve Deputy since 1990 and is a two-time Medal of Valor recipient from the Los Angeles County Sheriff's Department.- David J. Katz，自2020年3月起担任执行副总裁兼首席法务官。Katz先生自2021年4月起担任公司秘书。Katz先生从国际律师事务所Perkins Coie LLP加入雷网，在那里他担任了20年的合伙人。在加入雷网之前，Katz先生已经私人执业30年。Katz先生负责监督雷网的所有法律事务，包括但不限于合并、收购、证券和合资企业。卡茨先生自1990年以来还担任洛杉矶县警长预备役副手，曾两次获得洛杉矶县警长部门的英勇勋章。
- David J. Katz,has served as Executive Vice President and Chief Legal Officer since March 2020. Mr. Katz has served as Corporate Secretary since April 2021. Mr. Katz joined RadNet from the international law firm Perkins Coie LLP, where he was a partner for 20 years. Mr. Katz was in private practice for 30 years before joining RadNet. Mr. Katz is responsible for overseeing all of RadNet's legal matters including, without limitation, mergers, acquisitions, securities and joint ventures. Mr. Katz has also served as a Los Angeles County Sheriff Reserve Deputy since 1990 and is a two-time Medal of Valor recipient from the Los Angeles County Sheriff's Department.
- Ranjan Jayanathan
Ranjan Jayanathan，现任执行副总裁兼首席信息官，同时担任公司信息技术部门eRAD的总经理。Jayanathan先生于2010年从Voyant Health加入雷网，曾担任美国业务总经理。在加入Voyant之前，他是Dynamic Imaging执行管理团队的一员。在Dynamic Imaging的九年任期内，Jayanathan先生管理销售、客户服务和解决方案架构。他协助Dynamic Imaging于2007年出售给通用电气并将其整合到GE的运营中。在加入Dynamic Imaging之前，他曾在Advanced Radiology、Reynolds and Reynolds以及National Medical Computer Services担任过多个首席信息官和研发职位。Jayanathan先生获得了麻省理工学院的电气工程学位。
Ranjan Jayanathan,currently serves as Executive Vice President and Chief Information Officer, and also serves as General Manager of eRAD, the Company's information technology division. Mr. Jayanathan joined RadNet in 2010 from Voyant Health, where he was the General Manager of American operations. Prior to Voyant, he was a member of the executive management team of Dynamic Imaging. During his nine-year tenure at Dynamic Imaging, Mr. Jayanathan managed sales, client services, and solutions architecture. He assisted with Dynamic Imaging's sale to General Electric in 2007 and its integration into GE's operations. Prior to Dynamic Imaging, he held various Chief Information Officer and Research and Development positions at Advanced Radiology, Reynolds and Reynolds, and National Medical Computer Services. Mr. Jayanathan earned a degree in electrical engineering from the Massachusetts Institute of Technology.- Ranjan Jayanathan，现任执行副总裁兼首席信息官，同时担任公司信息技术部门eRAD的总经理。Jayanathan先生于2010年从Voyant Health加入雷网，曾担任美国业务总经理。在加入Voyant之前，他是Dynamic Imaging执行管理团队的一员。在Dynamic Imaging的九年任期内，Jayanathan先生管理销售、客户服务和解决方案架构。他协助Dynamic Imaging于2007年出售给通用电气并将其整合到GE的运营中。在加入Dynamic Imaging之前，他曾在Advanced Radiology、Reynolds and Reynolds以及National Medical Computer Services担任过多个首席信息官和研发职位。Jayanathan先生获得了麻省理工学院的电气工程学位。
- Ranjan Jayanathan,currently serves as Executive Vice President and Chief Information Officer, and also serves as General Manager of eRAD, the Company's information technology division. Mr. Jayanathan joined RadNet in 2010 from Voyant Health, where he was the General Manager of American operations. Prior to Voyant, he was a member of the executive management team of Dynamic Imaging. During his nine-year tenure at Dynamic Imaging, Mr. Jayanathan managed sales, client services, and solutions architecture. He assisted with Dynamic Imaging's sale to General Electric in 2007 and its integration into GE's operations. Prior to Dynamic Imaging, he held various Chief Information Officer and Research and Development positions at Advanced Radiology, Reynolds and Reynolds, and National Medical Computer Services. Mr. Jayanathan earned a degree in electrical engineering from the Massachusetts Institute of Technology.
- A. Gregory Sorensen
A. Gregory Sorensen，于2023年8月被任命为首席科学官和董事。Sorensen博士曾担任该公司旗下专注于Radnet，Inc. ing人工智能和深度学习方法的DeepHealth，Inc.（“DeepHealth”）子公司的首席执行官，该公司以乳腺癌成像为重点推进医疗保健。公司于2020年6月收购DeepHealth。Sorensen博士曾于2011年至2015年担任Siemens Healthcare North America总裁兼首席执行官。在此之前，他曾在哈佛医学院担任教授，并在麻省总医院担任神经放射科医生，他曾于1990年至2011年在该医院工作。Sorensen博士目前担任：IMRIS Deerfield Imaging，Inc.的董事会执行主席，该公司专注于整合神经外科环境中的成像技术；RealMIDX，Inc.的董事会成员，这是一家由KonicaMinolta全资拥有的综合诊断公司；以及费森尤斯医疗 AG & Co KGaA的监事会成员，该公司是一家为慢性肾衰竭患者提供产品和服务的供应商。Sorensen博士曾于2018年至2023年在Siemens Healthineers担任监事会成员。Sorensen博士拥有加州理工学院生物学学士学位、杨百翰大学计算机科学硕士学位和哈佛医学院医学博士学位。
A. Gregory Sorensen,was appointed as Chief Science Officer and as a director in August 2023. Dr. Sorensen has served as the Chief Executive Officer of Radnet, Inc. DeepHealth, Inc. ("DeepHealth") subsidiary of the Company that is focused on Radnet, Inc. ing artificial intelligence and deep learning methods to advance medical care with a special emphasis on breast cancer imaging. The Company acquired DeepHealth in June 2020. Dr. Sorensen served as the President and Chief Executive Officer of Siemens Healthcare North America from 2011 to 2015. Prior to that, he served as a Professor at Harvard Medical School and as a neuroradiologist at Massachusetts General Hospital, where he worked from 1990 to 2011. Dr. Sorensen currently serves as: the Executive Chairman of the board of directors of IMRIS, Deerfield Imaging, Inc., which is focused on the integration of imaging technologies in a neurosurgical setting; a member of the board of directors for RealmIDX, Inc., an integrated diagnostics company wholly owned by KonicaMinolta; and a member of the Supervisory Board for Fresenius Medical Care AG & Co KGaA, a provider of products and services for people with chronic kidney failure. Dr. Sorensen served as a Supervisory Board Member at Siemens Healthineers from 2018 to 2023. Dr. Sorensen holds a B.S. in biology from the California Institute of Technology, an M.S. in computer science from Brigham Young University, and an M.D. degree from Harvard Medical School.- A. Gregory Sorensen，于2023年8月被任命为首席科学官和董事。Sorensen博士曾担任该公司旗下专注于Radnet，Inc. ing人工智能和深度学习方法的DeepHealth，Inc.（“DeepHealth”）子公司的首席执行官，该公司以乳腺癌成像为重点推进医疗保健。公司于2020年6月收购DeepHealth。Sorensen博士曾于2011年至2015年担任Siemens Healthcare North America总裁兼首席执行官。在此之前，他曾在哈佛医学院担任教授，并在麻省总医院担任神经放射科医生，他曾于1990年至2011年在该医院工作。Sorensen博士目前担任：IMRIS Deerfield Imaging，Inc.的董事会执行主席，该公司专注于整合神经外科环境中的成像技术；RealMIDX，Inc.的董事会成员，这是一家由KonicaMinolta全资拥有的综合诊断公司；以及费森尤斯医疗 AG & Co KGaA的监事会成员，该公司是一家为慢性肾衰竭患者提供产品和服务的供应商。Sorensen博士曾于2018年至2023年在Siemens Healthineers担任监事会成员。Sorensen博士拥有加州理工学院生物学学士学位、杨百翰大学计算机科学硕士学位和哈佛医学院医学博士学位。
- A. Gregory Sorensen,was appointed as Chief Science Officer and as a director in August 2023. Dr. Sorensen has served as the Chief Executive Officer of Radnet, Inc. DeepHealth, Inc. ("DeepHealth") subsidiary of the Company that is focused on Radnet, Inc. ing artificial intelligence and deep learning methods to advance medical care with a special emphasis on breast cancer imaging. The Company acquired DeepHealth in June 2020. Dr. Sorensen served as the President and Chief Executive Officer of Siemens Healthcare North America from 2011 to 2015. Prior to that, he served as a Professor at Harvard Medical School and as a neuroradiologist at Massachusetts General Hospital, where he worked from 1990 to 2011. Dr. Sorensen currently serves as: the Executive Chairman of the board of directors of IMRIS, Deerfield Imaging, Inc., which is focused on the integration of imaging technologies in a neurosurgical setting; a member of the board of directors for RealmIDX, Inc., an integrated diagnostics company wholly owned by KonicaMinolta; and a member of the Supervisory Board for Fresenius Medical Care AG & Co KGaA, a provider of products and services for people with chronic kidney failure. Dr. Sorensen served as a Supervisory Board Member at Siemens Healthineers from 2018 to 2023. Dr. Sorensen holds a B.S. in biology from the California Institute of Technology, an M.S. in computer science from Brigham Young University, and an M.D. degree from Harvard Medical School.
- Howard G. Berger
Howard G. Berger，自1987年起担任RadNet及其前身实体的总裁兼首席执行官。Berger博士在Illinois大学医学院获得医学博士学位，获得核医学委员会认证并接受过内科住院医师培训，还在加州大学系统的医学物理硕士课程中接受过培训。Berger博士还是拥有Beverly Radiology Medical Group III（“BRMG”）的实体的总裁或联合总裁。
Howard G. Berger,has served as President and Chief Executive Officer of RadNet and its predecessor entities since 1987. Dr. Berger received his M.D. at the University of Illinois Medical School, is Board Certified in Nuclear Medicine and trained in an Internal Medicine residency, as well as in a master's program in medical physics in the University of California system. Dr. Berger is also the president or co-president of the entities that own Beverly Radiology Medical Group III ("BRMG").- Howard G. Berger，自1987年起担任RadNet及其前身实体的总裁兼首席执行官。Berger博士在Illinois大学医学院获得医学博士学位，获得核医学委员会认证并接受过内科住院医师培训，还在加州大学系统的医学物理硕士课程中接受过培训。Berger博士还是拥有Beverly Radiology Medical Group III（“BRMG”）的实体的总裁或联合总裁。
- Howard G. Berger,has served as President and Chief Executive Officer of RadNet and its predecessor entities since 1987. Dr. Berger received his M.D. at the University of Illinois Medical School, is Board Certified in Nuclear Medicine and trained in an Internal Medicine residency, as well as in a master's program in medical physics in the University of California system. Dr. Berger is also the president or co-president of the entities that own Beverly Radiology Medical Group III ("BRMG").
- Norman R. Hames
Norman R. Hames，1996年起，他担任RadNet的执行官，目前担任我公司执行副总裁、西部业务首席运营官和公司秘书长。他20多年的行业经验，他监督加州设备运营的所有方面。他的管理团队由地区董事、经理和销售经理组成，负责应对加州设备、患者、付款人和咨询医生的每日担心。加入我公司前，他担任自己的公司Diagnostic Imaging Services, Inc.的总裁和首席执行官，该公司被我公司收购，拥有并运营南加州14个多模态图像设备。他的第一次运营图像中心经验来自于American Medical International，负责单个和多模态图像中心的发展。
Norman R. Hames,has served as an executive officer of RadNet since 1996 and currently serves as Radnet, Inc. President and Chief Operating Officer-Western Operations. Mr. Hames served on RadNet's Board of Directors from 2000 until his resignation in 2019. Applying his more than 30 years of experience in the industry, Mr. Hames oversees all aspects of Radnet, Inc. California and Arizona facility operations. Prior to joining RadNet, Mr. Hames was President and Chief Executive Officer of his own company, Diagnostic Imaging Services, Inc., which owned and operated 14 multi-modality imaging facilities throughout Southern California prior to its sale to RadNet. Mr. Hames gained his initial experience in operating imaging centers for American Medical international, or AMI, and was responsible for the development of AMl's single and multi-modality imaging centers.- Norman R. Hames，1996年起，他担任RadNet的执行官，目前担任我公司执行副总裁、西部业务首席运营官和公司秘书长。他20多年的行业经验，他监督加州设备运营的所有方面。他的管理团队由地区董事、经理和销售经理组成，负责应对加州设备、患者、付款人和咨询医生的每日担心。加入我公司前，他担任自己的公司Diagnostic Imaging Services, Inc.的总裁和首席执行官，该公司被我公司收购，拥有并运营南加州14个多模态图像设备。他的第一次运营图像中心经验来自于American Medical International，负责单个和多模态图像中心的发展。
- Norman R. Hames,has served as an executive officer of RadNet since 1996 and currently serves as Radnet, Inc. President and Chief Operating Officer-Western Operations. Mr. Hames served on RadNet's Board of Directors from 2000 until his resignation in 2019. Applying his more than 30 years of experience in the industry, Mr. Hames oversees all aspects of Radnet, Inc. California and Arizona facility operations. Prior to joining RadNet, Mr. Hames was President and Chief Executive Officer of his own company, Diagnostic Imaging Services, Inc., which owned and operated 14 multi-modality imaging facilities throughout Southern California prior to its sale to RadNet. Mr. Hames gained his initial experience in operating imaging centers for American Medical international, or AMI, and was responsible for the development of AMl's single and multi-modality imaging centers.
- Stephen M. Forthuber
Stephen M. Forthuber，自2006年Radnet，Inc.收购Radiologix，Inc.以来一直担任雷网执行官，目前担任RadNet, Inc.总裁兼首席运营官-东部运营。他于2000年1月加入Radiologix，曾担任东北地区运营区域总监、东北地区运营区域副总裁、高级副总裁兼首席开发官，并在出售给雷网时最终担任Radiologix的首席运营官。在加入Radiologix之前，Forthuber先生从1982年到1999年一直受雇于Per-Se Technologies，Inc.及其前身公司，在那里他承担着重要的医师执业管理和放射学运营职责。Forthuber先生获得了Virginia的William and Mary学院的工商管理学士学位。
Stephen M. Forthuber,has served as an executive officer of RadNet since Radnet, Inc. acquisition of Radiologix, Inc. in 2006 and currently serves as Radnet, Inc. President and Chief Operating Officer-Eastern Operations. He joined Radiologix in January 2000, serving as Regional Director of Operations, Northeast, Regional Vice President of Operations, Northeast, Senior Vice President and Chief Development Officer, and ultimately Chief Operating Officer of Radiologix at the time of the sale to RadNet. Prior to working at Radiologix, Mr. Forthuber was employed from 1982 until 1999 by Per-Se Technologies, Inc. and its predecessor companies, where he had significant physician practice management and radiology operations responsibilities. Mr. Forthuber received a B.A. in Business Administration from the College of William and Mary in Virginia.- Stephen M. Forthuber，自2006年Radnet，Inc.收购Radiologix，Inc.以来一直担任雷网执行官，目前担任RadNet, Inc.总裁兼首席运营官-东部运营。他于2000年1月加入Radiologix，曾担任东北地区运营区域总监、东北地区运营区域副总裁、高级副总裁兼首席开发官，并在出售给雷网时最终担任Radiologix的首席运营官。在加入Radiologix之前，Forthuber先生从1982年到1999年一直受雇于Per-Se Technologies，Inc.及其前身公司，在那里他承担着重要的医师执业管理和放射学运营职责。Forthuber先生获得了Virginia的William and Mary学院的工商管理学士学位。
- Stephen M. Forthuber,has served as an executive officer of RadNet since Radnet, Inc. acquisition of Radiologix, Inc. in 2006 and currently serves as Radnet, Inc. President and Chief Operating Officer-Eastern Operations. He joined Radiologix in January 2000, serving as Regional Director of Operations, Northeast, Regional Vice President of Operations, Northeast, Senior Vice President and Chief Development Officer, and ultimately Chief Operating Officer of Radiologix at the time of the sale to RadNet. Prior to working at Radiologix, Mr. Forthuber was employed from 1982 until 1999 by Per-Se Technologies, Inc. and its predecessor companies, where he had significant physician practice management and radiology operations responsibilities. Mr. Forthuber received a B.A. in Business Administration from the College of William and Mary in Virginia.
- Mark D. Stolper
Mark D. Stolper，自2004年7月起担任RadNet, Inc.执行副总裁兼首席财务官，在此之前是RadNet, Inc.董事会的独立成员。在加入RadNet之前，Stolper先生在投资银行、私募股权、风险资本投资和运营方面拥有丰富的经验。Stolper先生的职业生涯始于Dillon, Read and Co., Inc.的企业融资集团成员，与Dillon Read的附属主要投资集团Saratoga Partners LLP一起执行并购、公共和私人融资以及私募股权投资。在Dillon Read之后，Stolper先生加入了Archon Capital Partners，后者对媒体和娱乐公司进行了私募股权投资。Stolper先生还曾在Eastman Kodak工作，负责Kodak娱乐影像子公司（销售额为15亿美元）的业务发展。Stolper还是Broadstream Capital Partners的联合创始人，Broadstream Capital Partners是一家总部位于洛杉矶的投资银行公司，专注于为从事融资和并购交易的中间市场公司提供咨询服务。Stolper先生自2017年3月起担任Surgalign Holdings, Inc.（纳斯达克股票代码：SRGA）的董事会成员，自2021年1月起担任Coherus BioSciences，Inc.（纳斯达克股票代码：CHRS）的董事会成员。2012年12月至2016年12月期间，他担任On Track Innovations, Ltd.（纳斯达克股票代码：OTIV）的董事会成员和审计委员会成员。他还曾在2010年4月至2012年12月出售期间担任Metropolitan Health Networks, Inc.（NYSE：MDF）的董事会和审计委员会成员，是一家提供折扣票务服务和品牌赛事商品推销的私营娱乐公司的董事会成员，并且是一家私营远程医疗和易康供应商的董事会主席。Stolper先生毕业于Pennsylvania大学文科学位和Wharton商学院金融学位。此外，Stolper先生还获得了California大学洛杉矶分校会计学研究生奖。
Mark D. Stolper,has served as Radnet, Inc. Executive Vice President and Chief Financial Officer since July 2004 and prior to that was an independent member of Radnet, Inc. Board of Directors. Prior to joining RadNet, Mr. Stolper had diverse experiences in investment banking, private equity, venture capital investing and operations. Mr. Stolper began his career as a member of the corporate finance group at Dillon, Read and Co., Inc., executing mergers and acquisitions, public and private financings, and private equity investments with Saratoga Partners LLP, an affiliated principal investment group of Dillon Read. After Dillon Read, Mr. Stolper joined Archon Capital Partners, which made private equity investments in media and entertainment companies. Mr. Stolper also worked for Eastman Kodak, where he was responsible for business development for Kodak's Entertainment Imaging subsidiary ($1.5 billion in sales). Mr. Stolper was also co-founder of Broadstream Capital Partners, a Los Angeles based investment banking firm focused on advising middle market companies engaged in financing and merger and acquisition transactions. Mr. Stolper has been a member of the board of directors of Surgalign Holdings, Inc. (NASDAQ: SRGA) since March 2017 and Coherus BioSciences, Inc. (NASDAQ: CHRS) since January 2021. He was a member of the board of directors and audit committee for On Track Innovations, Ltd. (NASDAQ: OTIV) from December 2012 until December 2016. He was also previously a member of the board of directors and audit committee for Metropolitan Health Networks, Inc. (NYSE: MDF) from April 2010 until its sale in December 2012, was a member of the board of directors for a privately held entertainment company providing discount ticketing services and branded event merchandising and was Chairman of the board for a private telemedicine and eHealth provider. Mr. Stolper graduated with a liberal arts degree from the University of Pennsylvania and a finance degree from the Wharton School. Additionally, Mr. Stolper earned a postgraduate Award in Accounting from the University of California, Los Angeles.- Mark D. Stolper，自2004年7月起担任RadNet, Inc.执行副总裁兼首席财务官，在此之前是RadNet, Inc.董事会的独立成员。在加入RadNet之前，Stolper先生在投资银行、私募股权、风险资本投资和运营方面拥有丰富的经验。Stolper先生的职业生涯始于Dillon, Read and Co., Inc.的企业融资集团成员，与Dillon Read的附属主要投资集团Saratoga Partners LLP一起执行并购、公共和私人融资以及私募股权投资。在Dillon Read之后，Stolper先生加入了Archon Capital Partners，后者对媒体和娱乐公司进行了私募股权投资。Stolper先生还曾在Eastman Kodak工作，负责Kodak娱乐影像子公司（销售额为15亿美元）的业务发展。Stolper还是Broadstream Capital Partners的联合创始人，Broadstream Capital Partners是一家总部位于洛杉矶的投资银行公司，专注于为从事融资和并购交易的中间市场公司提供咨询服务。Stolper先生自2017年3月起担任Surgalign Holdings, Inc.（纳斯达克股票代码：SRGA）的董事会成员，自2021年1月起担任Coherus BioSciences，Inc.（纳斯达克股票代码：CHRS）的董事会成员。2012年12月至2016年12月期间，他担任On Track Innovations, Ltd.（纳斯达克股票代码：OTIV）的董事会成员和审计委员会成员。他还曾在2010年4月至2012年12月出售期间担任Metropolitan Health Networks, Inc.（NYSE：MDF）的董事会和审计委员会成员，是一家提供折扣票务服务和品牌赛事商品推销的私营娱乐公司的董事会成员，并且是一家私营远程医疗和易康供应商的董事会主席。Stolper先生毕业于Pennsylvania大学文科学位和Wharton商学院金融学位。此外，Stolper先生还获得了California大学洛杉矶分校会计学研究生奖。
- Mark D. Stolper,has served as Radnet, Inc. Executive Vice President and Chief Financial Officer since July 2004 and prior to that was an independent member of Radnet, Inc. Board of Directors. Prior to joining RadNet, Mr. Stolper had diverse experiences in investment banking, private equity, venture capital investing and operations. Mr. Stolper began his career as a member of the corporate finance group at Dillon, Read and Co., Inc., executing mergers and acquisitions, public and private financings, and private equity investments with Saratoga Partners LLP, an affiliated principal investment group of Dillon Read. After Dillon Read, Mr. Stolper joined Archon Capital Partners, which made private equity investments in media and entertainment companies. Mr. Stolper also worked for Eastman Kodak, where he was responsible for business development for Kodak's Entertainment Imaging subsidiary ($1.5 billion in sales). Mr. Stolper was also co-founder of Broadstream Capital Partners, a Los Angeles based investment banking firm focused on advising middle market companies engaged in financing and merger and acquisition transactions. Mr. Stolper has been a member of the board of directors of Surgalign Holdings, Inc. (NASDAQ: SRGA) since March 2017 and Coherus BioSciences, Inc. (NASDAQ: CHRS) since January 2021. He was a member of the board of directors and audit committee for On Track Innovations, Ltd. (NASDAQ: OTIV) from December 2012 until December 2016. He was also previously a member of the board of directors and audit committee for Metropolitan Health Networks, Inc. (NYSE: MDF) from April 2010 until its sale in December 2012, was a member of the board of directors for a privately held entertainment company providing discount ticketing services and branded event merchandising and was Chairman of the board for a private telemedicine and eHealth provider. Mr. Stolper graduated with a liberal arts degree from the University of Pennsylvania and a finance degree from the Wharton School. Additionally, Mr. Stolper earned a postgraduate Award in Accounting from the University of California, Los Angeles.
- Michael N. Murdock
Michael N. Murdock，自2021年起担任RadNet, Inc.并购业务执行副总裁。Murdock先生于2006年11月在RadNet收购Radiologix公司后加入RadNet。Murdock先生自2005年1月起担任Radiologix的高级副总裁兼首席财务官。Murdock职业生涯的大部分时间都在医疗保健公司担任高级财务职位，包括在American Medical International及其继任者American Medical Holdings，Inc.任职，后者是一家收入24亿美元的急症护理设施的公开交易所有者和运营商，该公司已被National Medical Enterprises收购，现为Tenet Healthcare。Murdock先生还曾担任Physician Reliance Network，Inc.的首席财务官，该公司是一家营收3.98亿美元的上市医生实践管理公司，专门从事肿瘤学领域的研究。1999年，PRN与American Oncology，Inc.合并，成为U.S. Oncology，Inc.，这是美国最大的致力于癌症治疗和研究的医疗保健网络。从1999年到2004年，Murdock先生担任Dental One的首席财务官，该公司是一家风险资本支持的所有者和运营商，在Texas、Arizona、Colorado和Utah拥有48家牙科诊所。Murdock于1978年开始了他的职业生涯，在获得California State大学Northridge分校的学士学位后，他在Arthur Andersen担任审计员。
Michael N. Murdock,has served as Radnet, Inc. Executive Vice President, Mergers and Acquisitions since 2021. Mr. Murdock joined RadNet in November of 2006 upon the acquisition of Radiologix by RadNet. Mr. Murdock was Senior Vice President and Chief Financial Officer of Radiologix since January 2005. Mr. Murdock has spent the majority of his career in senior financial positions with health care companies, including positions with American Medical International and its successor American Medical Holdings, Inc., a $2.4 billion in revenue publicly traded owner and operator of acute care facilities that was acquired by National Medical Enterprises, now Tenet Healthcare. Mr. Murdock also served as Chief Financial Officer of Physician Reliance Network, Inc., a $398 million in revenue publicly traded physician practice management company, specializing in oncology. In 1999, PRN merged with American Oncology, Inc. to become U.S. Oncology, Inc., the nation's largest healthcare network dedicated to cancer treatment and research. From 1999 through 2004, Mr. Murdock served as CFO of Dental One, a venture capital-backed owner and operator of 48 dental practices in Texas, Arizona, Colorado, and Utah. Mr. Murdock began his career in 1978 as an auditor with Arthur Andersen after receiving a B.S. degree from California State University, Northridge.- Michael N. Murdock，自2021年起担任RadNet, Inc.并购业务执行副总裁。Murdock先生于2006年11月在RadNet收购Radiologix公司后加入RadNet。Murdock先生自2005年1月起担任Radiologix的高级副总裁兼首席财务官。Murdock职业生涯的大部分时间都在医疗保健公司担任高级财务职位，包括在American Medical International及其继任者American Medical Holdings，Inc.任职，后者是一家收入24亿美元的急症护理设施的公开交易所有者和运营商，该公司已被National Medical Enterprises收购，现为Tenet Healthcare。Murdock先生还曾担任Physician Reliance Network，Inc.的首席财务官，该公司是一家营收3.98亿美元的上市医生实践管理公司，专门从事肿瘤学领域的研究。1999年，PRN与American Oncology，Inc.合并，成为U.S. Oncology，Inc.，这是美国最大的致力于癌症治疗和研究的医疗保健网络。从1999年到2004年，Murdock先生担任Dental One的首席财务官，该公司是一家风险资本支持的所有者和运营商，在Texas、Arizona、Colorado和Utah拥有48家牙科诊所。Murdock于1978年开始了他的职业生涯，在获得California State大学Northridge分校的学士学位后，他在Arthur Andersen担任审计员。
- Michael N. Murdock,has served as Radnet, Inc. Executive Vice President, Mergers and Acquisitions since 2021. Mr. Murdock joined RadNet in November of 2006 upon the acquisition of Radiologix by RadNet. Mr. Murdock was Senior Vice President and Chief Financial Officer of Radiologix since January 2005. Mr. Murdock has spent the majority of his career in senior financial positions with health care companies, including positions with American Medical International and its successor American Medical Holdings, Inc., a $2.4 billion in revenue publicly traded owner and operator of acute care facilities that was acquired by National Medical Enterprises, now Tenet Healthcare. Mr. Murdock also served as Chief Financial Officer of Physician Reliance Network, Inc., a $398 million in revenue publicly traded physician practice management company, specializing in oncology. In 1999, PRN merged with American Oncology, Inc. to become U.S. Oncology, Inc., the nation's largest healthcare network dedicated to cancer treatment and research. From 1999 through 2004, Mr. Murdock served as CFO of Dental One, a venture capital-backed owner and operator of 48 dental practices in Texas, Arizona, Colorado, and Utah. Mr. Murdock began his career in 1978 as an auditor with Arthur Andersen after receiving a B.S. degree from California State University, Northridge.